Forabosco Paola, Bouzigon Emmanuelle, Ng Mandy Y, Hermanowski Jane, Fisher Sheila A, Criswell Lindsey A, Lewis Cathryn M
King's College London School of Medicine, Department of Medical and Molecular Genetics, London, UK.
Eur J Hum Genet. 2009 Feb;17(2):236-43. doi: 10.1038/ejhg.2008.163. Epub 2008 Sep 10.
Autoimmune diseases are chronic disorders initiated by a loss of immunologic tolerance to self-antigens. They cluster within families, and patients may be diagnosed with more than one disease, suggesting pleiotropic genes are involved in the aetiology of different diseases. To identify potential loci, which confer susceptibility to autoimmunity independent of disease phenotype, we pooled results from genome-wide linkage studies, using the genome scan meta-analysis method (GSMA). The meta-analysis included 42 independent studies for 11 autoimmune diseases, using 7350 families with 18 291 affected individuals. In addition to the HLA region, which showed highly significant genome-wide evidence for linkage, we obtained suggestive evidence for linkage on chromosome 16, with peak evidence at 10.0-19.8 Mb. This region may harbour a pleiotropic gene (or genes) conferring risk for several diseases, although no such gene has been identified through association studies. We did not identify evidence for linkage at several genes known to confer increased risk to different autoimmune diseases (PTPN22, CTLA4), even in subgroups of diseases consistently found to be associated with these genes. The relative risks conferred by variants in these genes are modest (<1.5 in most cases), and even a large study like this meta-analysis lacks power to detect linkage. This study illustrates the concept that linkage and association studies have power to identify very different types of disease-predisposing variants.
自身免疫性疾病是由对自身抗原的免疫耐受性丧失引发的慢性疾病。它们在家族中聚集,患者可能被诊断出患有不止一种疾病,这表明多效性基因参与了不同疾病的病因。为了识别与自身免疫易感性相关的潜在基因座,而不考虑疾病表型,我们使用基因组扫描荟萃分析方法(GSMA)汇总了全基因组连锁研究的结果。该荟萃分析纳入了针对11种自身免疫性疾病的42项独立研究,涉及7350个家族中的18291名患病个体。除了显示出全基因组连锁的高度显著证据的HLA区域外,我们还获得了16号染色体上连锁的提示性证据,峰值证据位于10.0-19.8 Mb处。该区域可能存在一个(或多个)赋予多种疾病风险的多效性基因,尽管尚未通过关联研究鉴定出这样的基因。我们没有在已知会增加不同自身免疫性疾病风险的几个基因(PTPN22、CTLA4)中发现连锁证据,即使在一直发现与这些基因相关的疾病亚组中也是如此。这些基因中的变异所赋予的相对风险较小(大多数情况下<1.5),即使像这项荟萃分析这样的大型研究也缺乏检测连锁的能力。这项研究说明了连锁研究和关联研究有能力识别非常不同类型的疾病易感性变异这一概念。